Prognostic value of serum uric acid: New-onset in and out-of-office hypertension and long-term mortality

Journal of Hypertension

Volumn 32, Issue 6, 2014, Pages 1237-1244

  Bombelli, Michele ^a   Ronchi, Irene ^a   Volpe, Marco ^a   Facchetti, Rita ^a   Carugo, Stefano ^a   Dell'Oro, Raffaella ^a   Cuspidi, Cesare ^a,b   Grassi, Guido ^a,c   Mancia, Giuseppe ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

Author keywords

acid uric; all cause mortality; ambulatory blood pressure; cardiovascular mortality; cardiovascular risk factors; general population; home blood pressure; prognostic value

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; URIC ACID BLOOD LEVEL; ANTHROPOMETRY; BLOOD; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASES; HEART VENTRICLE; HEMODYNAMICS; ITALY; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANTHROPOMETRY; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HEMODYNAMICS; HUMANS; HYPERTENSION; ITALY; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; URIC ACID;

EID: 84900436007     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000161     Document Type: Article

References (27)

1. Verdecchia P, Schillaci G, Reboldi GP, Santeusanio F, Porcellati C, Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension the PIUMA study. Hypertension 2000; 36:1072-1078.
2. Lehto S, Niskanen L, Rönnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with noninsulin-dependent diabetes mellitus. Stroke 1998; 29:635-639.
3. Ndrepepa G, Braun S, King L, Cassese S, Tada T, Fusaro M, et al. Prognostic value of uric acid in patients with type 2 diabetes mellitus and coronary artery disease. Clin Sci (Lond) 2013; 124:259-268.
4. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006; 37:1503-1507.
5. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens 2008; 21:500-508.
6. Bombelli M, Facchetti R, Carugo S, Madotto F, Arenare F, Quarti-Trevano F, et al. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values. J Hypertens 2009; 27:2458-2464.
7. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al., Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348:2407-2415.
8. Sega R, Facchetti R, Bombelli M, Cesana GC, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111:1777-1783.
9. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A. Ambulatory blood pressure normality: results from the PAMELA Study. J Hypertens 1995; 13:1377-1390.
10. Sega R, Cesana G, Milesi C, Grassi G, Zanchetti A, Mancia G. Ambulatory and home blood pressure normality in the elderly data from the PAMELA population. Hypertension 1997; 30:1-6.
11. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55:613-661.
12. Cuspidi C, Giudici V, Lonati L, Sala C, Valerio C, Mancia G. Left ventricular hypertrophy detection and body mass index in essential hypertension. Blood Pressure 2010; 19:337-343.
13. Manual of international statistical classification of diseases, injuries and causes of death, IXth, revision. Geneva: WHO; 1977.
14. Groppelli A, Omboni S, Parati G, Mancia G. Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24 h intraarterial blood pressure. Hypertension 1992; 20:227-232.
15. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al., Task Force Members. 2013 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens 2013; 31:1281-1357.
16. Wiley Cox DR. Regression models and life tables (with discussion). J Royal Stat Soc Ser B 1972; 34:187-220.
17. Kelly MJ, Dunstan FD, Lloyd K, Fone DL. Evaluating cutpoints for the MHI-5 and MCS using the GHQ-12: a comparison of five different methods. BMC Psychiatry 2008; 8:10.
18. Rodrigues SL, Baldo MP, Capingana DP, Magalhães P, Dantas EM, Molina Mdel C, et al. Gender distribution of serum uric acid and cardiovascular risk factors: population based study. Arq Bras Cardiol 2012; 98:13-21.
19. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I, et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006; 19:1055-1062.
20. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiological follow-up study, 1971-1992. JAMA 2000; 283:2404-2410.
21. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality. Hypertension 2005; 46:156-161.
22. Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens 1998; 16:971-997.
23. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang D-H, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38:1101-1106.
24. Watanabe S, Kang D-H, Feng L, Nakagawa T, Kanellis J, Lan H, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40:356-360.
25. Ginsberg MH, Kozin F, O'Malley M, McCarty DJ. Release of platelet constituents by monosodium urate crystals. J Clin Invest 1997; 60:999-1007.
26. Zweier JL, Kuppusamy P, Lutty GA. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci USA 1988; 85:4046-4050.
27. DeScheeder IK, van de Kraay AM, Lamers JM, Koster JF, deJong JW, Serruys PW. Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during angioplasty: potential mechanisms for free radical generation. Am J Cardiol 1991; 68:392-395.